Cargando…
Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis
BACKGROUND: For research with human participants to be ethical, risk must be in a favorable balance with potential benefits. Little is known about the risk/benefit ratio for pediatric cancer phase II trials testing targeted therapies. OBJECTIVE: Our aim was to conduct a systematic review of prelimin...
Autores principales: | Strzebonska, Karolina, Wasylewski, Mateusz T., Zaborowska, Lucja, Polak, Maciej, Slugocka, Emilia, Stras, Jakub, Blukacz, Mateusz, Gyawali, Bishal, Waligora, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266705/ https://www.ncbi.nlm.nih.gov/pubmed/34110559 http://dx.doi.org/10.1007/s11523-021-00822-5 |
Ejemplares similares
-
Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
por: Strzebonska, Karolina, et al.
Publicado: (2022) -
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
por: Wasylewski, Mateusz T., et al.
Publicado: (2020) -
Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis
por: Strzebonska, Karolina, et al.
Publicado: (2020) -
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
por: Waligora, Marcin, et al.
Publicado: (2018) -
Umbrella and basket trials in oncology: ethical challenges
por: Strzebonska, Karolina, et al.
Publicado: (2019)